Endometrics logo — Time to end the silence

Endometrics

Time to end the silence

Founded 2021 United States San Francisco, United States 2 employees Pre-Seed Biotechnology, Health Care

General Information

Company Name Endometrics
Founded Year 2021
Location United States San Francisco, United States
Employees 2
Industries Biotechnology, Health Care
Funding Stage Pre-Seed
Social

BounceWatch is an independent company data service, not affiliated with Endometrics. To contact Endometrics, visit endometrics.us.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Endometrics compare?

A PDF of Endometrics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Endometrics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Endometrics

Endometrics is a biotechnology startup founded in 2021 with the slogan "Time to end the silence". The company is headquartered in the United States and is dedicated to developing a new genomic biomarker for the early detection of endometriosis.

Their most recent milestone includes securing Pre Seed Round investment on 01 January 2022 from Flatiron Investors. This financial backing signifies a vote of confidence from the venture capital community and provides Endometrics with crucial resources to drive their groundbreaking research forward.

With the rising importance of women's health in the healthcare industry, Endometrics' innovative approach to addressing endometriosis presents a compelling investment opportunity for venture capitalists looking to support cutting-edge advancements in both biotechnology and healthcare.

Business keywords: genomic biomarker, early detection, endometriosis, genomics, medical diagnostics, women's health, startups, innovation

Funding Rounds & Investors (1)

View All
Funding Stage Amount Investors Lead Investors Date
Pre Seed Round Undisclosed 1
Flatiron Investors
01 Jan 2022

Endometrics Alternatives & Competitors

View All Alternatives
Endometrics vs
Hera Biotech
Hera Biotech United States

Advancing the Standard of Care in Women's Health Diagnostics

Series A
12 employees
Biopharma, Biotechnology
Endometrics vs

Innovating women's health with AI-powered early detection through biomarkers.

Seed
2-10 employees
Biotechnology, Health Care
Endometrics vs
NanoMosaic Inc.
NanoMosaic Inc. United States

Next generation proteomics and multi-omics powered by nanoneedles

Series A
15 employees
Biopharma, Biotechnology

FAQ About Endometrics

Time to end the silence
Endometrics was founded in 2021.
Endometrics is headquartered in San Francisco, United States.
Endometrics operates in Biotechnology and Health Care. Its work centres on genomic biomarker, early detection, endometriosis and genomics.
Endometrics has approximately 2 employees.
Endometrics has completed 1 funding round. The latest funding stage is Pre-Seed.
Top alternatives and competitors to Endometrics include Hera Biotech, Gina Life, NanoMosaic Inc., Avellino, ArcanaBio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Endometrics and Hera Biotech are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Endometrics, https://bouncewatch.com/company/endometrics, updated 30 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes